{"groups":[{"description":"Mobilization with Filgrastim Stem Cell collection (SCC) Melphalan Conditioning Stem Cell infusion\n\nfilgrastim: 16 mcg/kg daily beginning 3 days prior to SCC through day before final SCC\n\nmelphalan: 70-100 mg/m2/day will be administered intravenously on Days -3 and -2\n\nStem Cell Infusion: infusion of previously collected stem cells on Day 0","id":"FG000","title":"SCT With Melphalan Conditioning"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"4"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"4"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}],"preAssignmentDetails":"A patient enrolled on this study but was withdrawn due to insufficient stem cell yield. His clinical situation changed 5 months later and the investigators believed he would have a better yield so he was enrolled for a second time. Therefore, there were 5 enrollments, but 4 patients.","recruitmentDetails":"Patients were enrolled from the Boston Medical Center Stem Cell Transplant Program between 2006 and 2009."}